HEREDITARY ANGIOEDEMA (HAE)
Clinical trials for HEREDITARY ANGIOEDEMA (HAE) explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA (HAE) trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA (HAE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Doctors track approved swelling drug in everyday use
Disease control Not yet recruitingThis study monitors how safe and effective Takhzyro is for teenagers and adults with hereditary angioedema (HAE) during routine medical care in South Korea. HAE causes sudden, severe swelling under the skin or inside the body. Researchers will track side effects and how well the …
Matched conditions: HEREDITARY ANGIOEDEMA (HAE)
Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Breakthrough HAE treatment enters final Long-Term testing phase
Disease control Not yet recruitingThis study continues testing ADX-324, an experimental treatment for hereditary angioedema (HAE), to see how safe and effective it is over a longer period. It's for people who already completed the main trial and have HAE types 1 or 2. Researchers will track side effects, count ho…
Matched conditions: HEREDITARY ANGIOEDEMA (HAE)
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Looking back: does this HAE drug work in everyday life?
Disease control Not yet recruitingThis study aims to understand how well the preventive drug Takhzyro works for people with hereditary angioedema (HAE) in real-world settings in Saudi Arabia. Researchers will review the medical records of about 50 patients who have taken the drug for at least six months to see if…
Matched conditions: HEREDITARY ANGIOEDEMA (HAE)
Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Algerian study aims to simplify diagnosis of rare swelling disorder
Diagnosis Not yet recruitingThis study aims to see if a simpler blood test that measures just one protein function can accurately diagnose hereditary angioedema (HAE), a rare condition causing sudden, serious swelling. Researchers in Algeria will compare this new test approach to the standard combination of…
Matched conditions: HEREDITARY ANGIOEDEMA (HAE)
Phase: NA • Sponsor: Takeda • Aim: Diagnosis
Last updated Mar 27, 2026 12:39 UTC
-
Researchers map the Real-World journey of rare swelling disorder patients
Knowledge-focused Not yet recruitingThis study aims to understand how hereditary angioedema (HAE) is diagnosed and treated in Egypt. It will look at the medical records of about 100 people with HAE and follow some of them during their regular doctor visits. The goal is to learn about their experiences, from first s…
Matched conditions: HEREDITARY ANGIOEDEMA (HAE)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC